Teva Pharmaceuticals USA recalls Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laborator…

Recall date

October 19, 2018

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0129-2019

FDA classification

Class II

Brand / firm

Teva Pharmaceuticals USA

Sold / distributed

U.S.A. Nationwide including Puerto Rico.

Why it was recalled

Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01